{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:04:18Z","timestamp":1794089058793,"version":"4.8.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"European Union\u2019s Horizon 2020","award":["634238"],"award-info":[{"award-number":["634238"]}]},{"name":"Swiss State Secretariat for Education, Research, and Innovation","award":["15.0137"],"award-info":[{"award-number":["15.0137"]}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["SNSF 320030_188549 and 325130_204361\/1"],"award-info":[{"award-number":["SNSF 320030_188549 and 325130_204361\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["PZ00P3_201672"],"award-info":[{"award-number":["PZ00P3_201672"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-025-06579-0","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:11:45Z","timestamp":1764076305000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prescribing and deprescribing of atypical antipsychotics in older multimorbid patients"],"prefix":"10.1186","volume":"25","author":[{"given":"Claudio","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis","family":"O\u2019Mahony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivia","family":"Dalleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Spinewine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corlina J.A.","family":"Huibers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Rodondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole Elodie","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"6579_CR1","volume-title":"StatPearls","author":"K Chokhawala","year":"2024","unstructured":"Chokhawala K, Stevens L. StatPearls. Antipsychotic Medications; 2024."},{"key":"6579_CR2","volume-title":"Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults","author":"R Christian","year":"2012","unstructured":"Christian R, Saavedra L, Gaynes BN, Sheitman B, Wines RCM, Jonas DE, et al. Future Research Needs for First- and Second-Generation Antipsychotics for Children and Young Adults. AHRQ Future Research Needs Papers; 2012. Rockville (MD)."},{"key":"6579_CR3","unstructured":"Swissmedic. Swissmedicinfo Cited 2024. Available from: https:\/\/www.swissmedicinfo.ch\/"},{"key":"6579_CR4","unstructured":"European Medical Agency (EMA). European Public Assessment Reports. 2024. Available from: https:\/\/www.ema.europa.eu\/en\/medicines. Accessed Sept 10 2025."},{"key":"6579_CR5","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1017\/S2045796021000159","volume":"30","author":"M Hojlund","year":"2021","unstructured":"Hojlund M, Andersen JH, Andersen K, Correll CU, Hallas J. Use of antipsychotics in Denmark 1997\u20132018: a nation-wide drug utilisation study with focus on off-label use and associated diagnoses. Epidemiol Psychiatr Sci. 2021;30:e28.","journal-title":"Epidemiol Psychiatr Sci"},{"issue":"5 Suppl B","key":"6579_CR6","first-page":"S1","volume":"18","author":"AR Maher","year":"2012","unstructured":"Maher AR, Theodore G. Summary of the comparative effectiveness review on off-label use of atypical antipsychotics. J Manag Care Pharm. 2012;18(5 Suppl B):S1\u201320.","journal-title":"J Manag Care Pharm"},{"key":"6579_CR7","first-page":"6","volume":"Spec No","author":"GS Alexopoulos","year":"2005","unstructured":"Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. Postgrad Med. 2005;Spec No:6\u201322.","journal-title":"Postgrad Med"},{"issue":"15","key":"6579_CR8","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","volume":"294","author":"LS Schneider","year":"2005","unstructured":"Schneider LS, Dagerman KS, Insel P. Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA. 2005;294(15):1934\u201343.","journal-title":"JAMA"},{"key":"6579_CR9","first-page":"1363","volume":"9","author":"P Gareri","year":"2014","unstructured":"Gareri P, Segura-Garcia C, Manfredi VG, Bruni A, Ciambrone P, Cerminara G, et al. Use of atypical antipsychotics in the elderly: a clinical review. Clin Interv Aging. 2014;9:1363\u201373.","journal-title":"Clin Interv Aging"},{"issue":"10","key":"6579_CR10","first-page":"29","volume":"5","author":"JD Markowitz","year":"2008","unstructured":"Markowitz JD, Narasimhan M. Delirium and antipsychotics: a systematic review of epidemiology and somatic treatment options. Psychiatry (Edgmont). 2008;5(10):29\u201336.","journal-title":"Psychiatry (Edgmont)"},{"issue":"3","key":"6579_CR11","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41386-021-01163-7","volume":"47","author":"N Stogios","year":"2022","unstructured":"Stogios N, Smith E, Bowden S, Tran V, Asgariroozbehani R, McIntyre WB, et al. Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis. Neuropsychopharmacology. 2022;47(3):664\u201372.","journal-title":"Neuropsychopharmacology"},{"key":"6579_CR12","doi-asserted-by":"publisher","first-page":"e076268","DOI":"10.1136\/bmj-2023-076268","volume":"385","author":"PLH Mok","year":"2024","unstructured":"Mok PLH, Carr MJ, Guthrie B, Morales DR, Sheikh A, Elliott RA, et al. Multiple adverse outcomes associated with antipsychotic use in people with dementia: population based matched cohort study. BMJ. 2024;385:e076268.","journal-title":"BMJ"},{"issue":"7","key":"6579_CR13","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s40263-013-0079-5","volume":"27","author":"A Cerovecki","year":"2013","unstructured":"Cerovecki A, Musil R, Klimke A, Seemuller F, Haen E, Schennach R, et al. Withdrawal symptoms and rebound syndromes associated with switching and discontinuing atypical antipsychotics: theoretical background and practical recommendations. CNS Drugs. 2013;27(7):545\u201372.","journal-title":"CNS Drugs"},{"issue":"1","key":"6579_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.sapharm.2017.01.003","volume":"14","author":"B Farrell","year":"2018","unstructured":"Farrell B, Richardson L, Raman-Wilms L, de Launay D, Alsabbagh MW, Conklin J. Self-efficacy for deprescribing: A survey for health care professionals using evidence-based deprescribing guidelines. Res Social Adm Pharm. 2018;14(1):18\u201325.","journal-title":"Res Social Adm Pharm"},{"key":"6579_CR15","unstructured":"Smartermedicine CWS. Top-5-Listen - Station\u00e4re Allgemeine Innere Medizin (2023) 2023 [Available from: https:\/\/www.smartermedicine.ch\/de\/top-5-listen\/stationaere-allgemeine-innere-medizin-2023"},{"issue":"12","key":"6579_CR16","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1001\/jamainternmed.2015.5441","volume":"175","author":"A Rosenberg","year":"2015","unstructured":"Rosenberg A, Agiro A, Gottlieb M, Barron J, Brady P, Liu Y, et al. Early trends among seven recommendations from the choosing wisely campaign. JAMA Intern Med. 2015;175(12):1913\u201320.","journal-title":"JAMA Intern Med"},{"issue":"4","key":"6579_CR17","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1111\/1468-0009.12531","volume":"99","author":"BQ Cliff","year":"2021","unstructured":"Cliff BQ, Avancena ALV, Hirth RA, Lee SD. The impact of choosing wisely interventions on Low-Value medical services: A systematic review. Milbank Q. 2021;99(4):1024\u201358.","journal-title":"Milbank Q"},{"issue":"2","key":"6579_CR18","first-page":"123","volume":"73","author":"NA Goto","year":"2025","unstructured":"Goto NA, van Heel DAM, Dautzenberg L, Sibille FX, Jennings E, Bauer DC, et al. Impact of discontinuation of Fall-Risk-Increasing drugs on falls in multimorbid older patients with polypharmacy. J Am Geriatr Soc. 2025;73(2):123\u201332.","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"6579_CR19","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/jgs.13943","volume":"64","author":"SJ Herzig","year":"2016","unstructured":"Herzig SJ, Rothberg MB, Guess JR, Stevens JP, Marshall J, Gurwitz JH, et al. Antipsychotic use in hospitalized adults: Rates, Indications, and predictors. J Am Geriatr Soc. 2016;64(2):299\u2013305.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"6579_CR20","doi-asserted-by":"publisher","first-page":"e026769","DOI":"10.1136\/bmjopen-2018-026769","volume":"9","author":"L Adam","year":"2019","unstructured":"Adam L, Moutzouri E, Baumgartner C, Loewe AL, Feller M, M\u2019Rabet-Bensalah K, et al. Rationale and design of optimising therapy to prevent avoidable hospital admissions in multimorbid older people (OPERAM): a cluster randomised controlled trial. BMJ Open. 2019;9(6):e026769.","journal-title":"BMJ Open"},{"key":"6579_CR21","doi-asserted-by":"publisher","first-page":"n1585","DOI":"10.1136\/bmj.n1585","volume":"374","author":"MR Blum","year":"2021","unstructured":"Blum MR, Sallevelt B, Spinewine A, O\u2019Mahony D, Moutzouri E, Feller M, et al. Optimizing therapy to prevent avoidable hospital admissions in multimorbid older adults (OPERAM): cluster randomised controlled trial. BMJ. 2021;374:n1585.","journal-title":"BMJ"},{"issue":"2","key":"6579_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony D, O\u2019Sullivan D, Byrne S, O\u2019Connor MN, Ryan C, Gallagher P. STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing. 2015;44(2):213\u20138.","journal-title":"Age Ageing"},{"key":"6579_CR23","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index 2024 2024 [Available from: https:\/\/atcddd.fhi.no\/atc_ddd_index\/"},{"key":"6579_CR24","unstructured":"Maglione M, Maher AR, Hu J, Wang Z, Shanman R, Shekelle PG, et al. Off-label use of atypical Antipsychotics: an update. AHRQ Comparative Effectiveness Reviews. Rockville\u00a0(MD): 2011."},{"issue":"12","key":"6579_CR25","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1001\/jama.2011.1360","volume":"306","author":"AR Maher","year":"2011","unstructured":"Maher AR, Maglione M, Bagley S, Suttorp M, Hu JH, Ewing B, et al. Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults: a systematic review and meta-analysis. JAMA. 2011;306(12):1359\u201369.","journal-title":"JAMA"},{"key":"6579_CR26","unstructured":"National Institute for Health and Care Excellence (NICE) Guideline [NG97]. Dementia: Assessment, management and support for people living with dementia and their carers. London. 2018. Available from: https:\/\/www.nice.org.uk\/guidance\/ng97. Accessed on Sept 10 2025."},{"issue":"7","key":"6579_CR27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s00115-023-01492-6","volume":"94","author":"F Jessen","year":"2023","unstructured":"Jessen F, Bohr L, Kruse C, Dodel R. [The German S3 guidelines on dementia]. Nervenarzt. 2023;94(7):609\u201313.","journal-title":"Nervenarzt"},{"issue":"24","key":"6579_CR28","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1055\/s-0043-106992","volume":"142","author":"S Braune","year":"2017","unstructured":"Braune S, Gurlit S. [Management of delirium in the intensive care Unit]. Dtsch Med Wochenschr. 2017;142(24):1820\u20134.","journal-title":"Dtsch Med Wochenschr"},{"key":"6579_CR29","unstructured":"National Institute for Health and Care Excellence (NICE). Guidelines. Autism spectrum disorder in under 19s: support and management. National Institute for Health and Care Excellence: Clinical Guidelines. London2021."},{"key":"6579_CR30","unstructured":"National Institute for Health and Care Excellence (NICE). Guidelines. Obsessive-Compulsive Disorder: Core Interventions in the Treatment of Obsessive-Compulsive Disorder and Body Dysmorphic Disorder. National Institute for Health and Care Excellence: Guidelines; Leicester (UK)2006."},{"key":"6579_CR31","doi-asserted-by":"crossref","unstructured":"Kennedy SKF, Goodall S, Lee SF, DeAngelis C, Jocko A, Charbonneau F et al. 2020 ASCO, 2023 NCCN, 2023 MASCC\/ESMO, and 2019 CCO: a comparison of antiemetic guidelines for the treatment of chemotherapy-induced nausea and vomiting in cancer patients. Support Care Cancer. 2024;32(5):280.","DOI":"10.1007\/s00520-024-08462-x"},{"issue":"5","key":"6579_CR32","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1007\/s11096-019-00866-8","volume":"41","author":"LM Kalisch Ellett","year":"2019","unstructured":"Kalisch Ellett LM, Pratt NL, Apajee J, Roughead EE. Initiation and continuation of antipsychotic medicines in older people following non-psychiatric hospital admission. Int J Clin Pharm. 2019;41(5):1341\u20137.","journal-title":"Int J Clin Pharm"},{"issue":"9","key":"6579_CR33","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1176\/appi.ajp.2012.12030342","volume":"169","author":"M Steinberg","year":"2012","unstructured":"Steinberg M, Lyketsos CG. Atypical antipsychotic use in patients with dementia: managing safety concerns. Am J Psychiatry. 2012;169(9):900\u20136.","journal-title":"Am J Psychiatry"},{"issue":"11","key":"6579_CR34","doi-asserted-by":"publisher","first-page":"775","DOI":"10.7326\/0003-4819-146-11-200706050-00006","volume":"146","author":"SS Gill","year":"2007","unstructured":"Gill SS, Bronskill SE, Normand SL, Anderson GM, Sykora K, Lam K, et al. Antipsychotic drug use and mortality in older adults with dementia. Ann Intern Med. 2007;146(11):775\u201386.","journal-title":"Ann Intern Med"},{"issue":"5","key":"6579_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1176\/appi.ajp.2015.173501","volume":"173","author":"VI Reus","year":"2016","unstructured":"Reus VI, Fochtmann LJ, Eyler AE, Hilty DM, Horvitz-Lennon M, Jibson MD, et al. The American psychiatric association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia. Am J Psychiatry. 2016;173(5):543\u20136.","journal-title":"Am J Psychiatry"},{"issue":"5","key":"6579_CR36","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.jagp.2024.09.010","volume":"33","author":"AD Zhang","year":"2025","unstructured":"Zhang AD, Zepel L, Woolson S, Miller KEM, Schleiden LJ, Shepherd-Banigan M, et al. Initiation and persistence of antipsychotic medications at hospital discharge among Community-Dwelling veterans with dementia. Am J Geriatr Psychiatry. 2025;33(5):500\u201311.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"1","key":"6579_CR37","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1001\/archinternmed.2009.456","volume":"170","author":"ER Dorsey","year":"2010","unstructured":"Dorsey ER, Rabbani A, Gallagher SA, Conti RM, Alexander GC. Impact of FDA black box advisory on antipsychotic medication use. Arch Intern Med. 2010;170(1):96\u2013103.","journal-title":"Arch Intern Med"},{"key":"6579_CR38","unstructured":"Medicines and Healthcare Products Regulatory Agency (MHRA). Message to healthcare professionals: ATYPICAL ANTIPSYCHOTIC DRUGS AND STROKE. 2004."},{"key":"6579_CR39","unstructured":"European Medicines Agency (EMA) Science Medicines Health. European public assessment report (EPAR) for Zyprexa Velotab - olanzapine. London: EMA. 2013. Available from https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/zyprexa-velotab. Accessed on September 10 2025."},{"issue":"11","key":"6579_CR40","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1007\/s40263-016-0366-z","volume":"30","author":"J Sultana","year":"2016","unstructured":"Sultana J, Fontana A, Giorgianni F, Pasqua A, Cricelli C, Spina E, et al. The effect of safety warnings on antipsychotic drug prescribing in elderly persons with dementia in the united Kingdom and italy: A Population-Based study. CNS Drugs. 2016;30(11):1097\u2013109.","journal-title":"CNS Drugs"},{"issue":"8","key":"6579_CR41","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1001\/jama.297.8.831","volume":"297","author":"S Kripalani","year":"2007","unstructured":"Kripalani S, LeFevre F, Phillips CO, Williams MV, Basaviah P, Baker DW. Deficits in communication and information transfer between hospital-based and primary care physicians: implications for patient safety and continuity of care. JAMA. 2007;297(8):831\u201341.","journal-title":"JAMA"},{"issue":"2","key":"6579_CR42","doi-asserted-by":"publisher","first-page":"88","DOI":"10.9740\/mhc.2019.03.088","volume":"9","author":"SV Phan","year":"2019","unstructured":"Phan SV, Lugin Y, Morgan K. Rates of new antipsychotic prescriptions and continuation at discharge from a medical unit in a community teaching hospital serving rural counties. Ment Health Clin. 2019;9(2):88\u201392.","journal-title":"Ment Health Clin"},{"issue":"12","key":"6579_CR43","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/jhm.2277","volume":"9","author":"KP Loh","year":"2014","unstructured":"Loh KP, Ramdass S, Garb JL, Brennan MJ, Lindenauer PK, Lagu T. From hospital to community: use of antipsychotics in hospitalized elders. J Hosp Med. 2014;9(12):802\u20134.","journal-title":"J Hosp Med"},{"issue":"10","key":"6579_CR44","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1111\/medu.14845","volume":"56","author":"JC Lauffenburger","year":"2022","unstructured":"Lauffenburger JC, Coll MD, Kim E, Robertson T, Oran R, Haff N, et al. Prescribing decision making by medical residents on night shifts: A qualitative study. Med Educ. 2022;56(10):1032\u201341.","journal-title":"Med Educ"},{"issue":"5","key":"6579_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.1365-2923.2009.03604.x","volume":"44","author":"N Brennan","year":"2010","unstructured":"Brennan N, Corrigan O, Allard J, Archer J, Barnes R, Bleakley A, et al. The transition from medical student to junior doctor: today\u2019s experiences of tomorrow\u2019s Doctors. Med Educ. 2010;44(5):449\u201358.","journal-title":"Med Educ"},{"issue":"12","key":"6579_CR46","doi-asserted-by":"publisher","first-page":"e006544","DOI":"10.1136\/bmjopen-2014-006544","volume":"4","author":"K Anderson","year":"2014","unstructured":"Anderson K, Stowasser D, Freeman C, Scott I. Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open. 2014;4(12):e006544.","journal-title":"BMJ Open"},{"issue":"2","key":"6579_CR47","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1001\/archinte.1992.00400140082019","volume":"152","author":"SE Levkoff","year":"1992","unstructured":"Levkoff SE, Evans DA, Liptzin B, Cleary PD, Lipsitz LA, Wetle TT, et al. Delirium. The occurrence and persistence of symptoms among elderly hospitalized patients. Arch Intern Med. 1992;152(2):334\u201340.","journal-title":"Arch Intern Med"},{"issue":"6","key":"6579_CR48","first-page":"CD005594","volume":"6","author":"L Burry","year":"2018","unstructured":"Burry L, Mehta S, Perreault MM, Luxenberg JS, Siddiqi N, Hutton B, et al. Antipsychotics for treatment of delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev. 2018;6(6):CD005594.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"6579_CR49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.7326\/M19-1860","volume":"171","author":"R Nikooie","year":"2019","unstructured":"Nikooie R, Neufeld KJ, Oh ES, Wilson LM, Zhang A, Robinson KA, et al. Antipsychotics for treating delirium in hospitalized adults: A systematic review. Ann Intern Med. 2019;171(7):485\u201395.","journal-title":"Ann Intern Med"},{"key":"6579_CR50","unstructured":"National Institute for Health and Care Excellence (NICE). Delirium in adults: Quality standard [QS63]. London: NICE. 2014. Available from: https:\/\/www.nice.org.uk\/guidance\/qs63\/chapter\/quality-statement-3-use-of-antipsychotic-medication-for-people-who-are-distressed. Accessed on September 10 2025."},{"key":"6579_CR51","doi-asserted-by":"crossref","unstructured":"Martinez C, Jones RW, Rietbrock S. Trends in the prevalence of antipsychotic drug use among patients with Alzheimer\u2019s disease and other dementias including those treated with antidementia drugs in the community in the UK: a cohort study. BMJ Open. 2013;3(1):e002080.","DOI":"10.1136\/bmjopen-2012-002080"},{"issue":"4","key":"6579_CR52","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1370\/afm.2094","volume":"15","author":"KA Wallis","year":"2017","unstructured":"Wallis KA, Andrews A, Henderson M. Swimming against the tide: primary care physicians\u2019 views on deprescribing in everyday practice. Ann Fam Med. 2017;15(4):341\u20136.","journal-title":"Ann Fam Med"},{"issue":"1","key":"6579_CR53","first-page":"17","volume":"64","author":"LM Bjerre","year":"2018","unstructured":"Bjerre LM, Farrell B, Hogel M, Graham L, Lemay G, McCarthy L, et al. Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline. Can Fam Physician. 2018;64(1):17\u201327.","journal-title":"Can Fam Physician"},{"issue":"4","key":"6579_CR54","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1080\/13607863.2016.1277974","volume":"22","author":"BL Olivieri-Mui","year":"2018","unstructured":"Olivieri-Mui BL, Devlin JW, Ochoa A, Schenck D, Briesacher B. Perceptions vs. evidence: therapeutic substitutes for antipsychotics in patients with dementia in long-term care. Aging Ment Health. 2018;22(4):544\u20139.","journal-title":"Aging Ment Health"},{"issue":"6","key":"6579_CR55","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.jamda.2021.12.043","volume":"23","author":"DA Harris","year":"2022","unstructured":"Harris DA, Maclagan LC, Iaboni A, Austin PC, Rosella LC, Maxwell CJ, et al. Potential unintended consequences of antipsychotic reduction in Ontario nursing homes. J Am Med Dir Assoc. 2022;23(6):1066\u201372. e7.","journal-title":"J Am Med Dir Assoc"},{"issue":"3","key":"6579_CR56","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s11096-024-01700-6","volume":"46","author":"A Bienfait","year":"2024","unstructured":"Bienfait A, Lagreula J, Blum MR, Rodondi N, Sallevelt B, Knol W, et al. Antipsychotic prescribing and drug-related readmissions in multimorbid older inpatients: a post-hoc analysis of the OPERAM population. Int J Clin Pharm. 2024;46(3):656\u201364.","journal-title":"Int J Clin Pharm"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06579-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-025-06579-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-025-06579-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:03:57Z","timestamp":1764079437000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgeriatr.biomedcentral.com\/articles\/10.1186\/s12877-025-06579-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6579"],"URL":"https:\/\/doi.org\/10.1186\/s12877-025-06579-0","relation":{},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"5 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the independent research ethics committees at each site (lead ethics committee: Cantonal Ethics Committee Bern, Switzerland, ID 2016\u201301200; Medical Research Ethics Committee Utrecht, Netherlands, ID 15\u2013522\/D; Comit\u00e9 d\u2019Ethique Hospitalo-Facultaire Saint-Luc-UCL: 2016\/20JUL\/347\u2013Belgian registration No: B403201629175; Cork University Teaching Hospitals Clinical Ethics Committee, Cork, Republic of Ireland; ID ECM 4 (o) 07\/02\/17), and Swissmedic as responsible regulatory authority. Written informed consent was obtained from the patients or their legal representatives before enrolment. This study adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethic approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"962"}}